AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Lorisita-M Fort Tablet PR

Prescription Icon
Prescription Required

Marketer

Lorioxindia Pharmaceuticals Private Limited

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Lorisita-M Fort Tablet PR

Combifort-DM tablets effectively manage elevated blood glucose in type 2 diabetes patients by combining two active ingredients. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risk. Combifort-DM may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes control; lifestyle significantly impacts disease management. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially when combined with insulin or sulfonylureas; patients must learn to identify and manage this complication. This medication isn't universally suitable. Individuals with pre-existing kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Potential drug interactions necessitate complete disclosure of all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor renal function and blood glucose levels throughout the treatment period.

Primary Ingredients of Lorisita-M Fort Tablet PR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Lorisita-M Fort Tablet PR

Managing type 2 diabetes

Major Benefits of Lorisita-M Fort Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Lorisita-M Fort Tablet PR with a meal.

Common Side effects of Lorisita-M Fort Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Lorisita-M Fort Tablet PR:

Follow your doctor's instructions or the package insert for proper administration. Take Lorisita-M Fort Tablet PR with a meal.

How Lorisita-M Fort Tablet PR works:

Lorisita-M Fort Tablet PR combines sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Lorisita-M Fort Tablet PR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lorisita-M Fort Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Lorisita-M Fort Tablet PR while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Lorisita-M Fort Tablet PR with careful consideration. A modified dosage may be necessary; physician consultation is recommended. Lorisita-M Fort Tablet PR is contraindicated in patients with severely compromised renal function. Close monitoring of kidney function is advised during treatment.

LiverLiverUNSAFE

The use of Lorisita-M Fort Tablet PR is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Lorisita-M Fort Tablet PR :

Should you forget a Lorisita-M Fort Tablet PR dose, take it immediately if you remember. But, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Lorisita-M Fort Tablet PR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Medication

FAQs on Lorisita-M Fort Tablet PR

Lorisita-M Fort Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Lorisita-M Fort Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Lorisita-M Fort Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Lorisita-M Fort Tablet PR components or excipients, or those experiencing severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Lorisita-M Fort Tablet PR and alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lorisita-M Fort Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Lorisita-M Fort Tablet PR combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Lorisita-M Fort Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Lorisita-M Fort Tablet PR is contraindicated in patients with known hypersensitivity to its components or excipients, and in those with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lorisita-M Fort Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lorisita-M Fort Tablet PR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is a reason to avoid metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lorisita-M Fort Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lorisita-M Fort Tablet PR combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Lorisita-M Fort Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Lorisita-M Fort Tablet PR is contraindicated in patients with hypersensitivity to its components or excipients, and those with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lorisita-M Fort Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lorisita-M Fort Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lorisita-M Fort Tablet PR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lorisita-M Fort Tablet PR
168
MRP 195
13% off